Home » HeartWare Lands Warning Letter for Validation, CAPA Concerns
HeartWare Lands Warning Letter for Validation, CAPA Concerns
Coronary device company HeartWare International said Wednesday that it received an FDA warning letter related to the company’s Miami Lakes, Fla., manufacturing facility.
Devices & Diagnostics Letter
Devices Inspections and AuditsDevices & Diagnostics Letter
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
20Jun
-
21Oct